Pre-pandemic remote monitoring enabled NYU Langone to reduce the need for outpatient clinic visits post-transplantation by two-thirds. The increased frequency of monitoring compared to in-clinic assessment also enabled the rapid identification of rejection or infection.
Discover More about RespiGene
RespiGene is a provider of digital innovative solutions that advance respiratory care and help to improve the lives of those affected by severe respiratory conditions such as COVID-19, COPD, asthma, pulmonary fibrosis, cystic fibrosis and lung transplantation.
